Yunnan Baiyao Group Co Ltd (000538.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE0000008X7

Price
53.29 CNY
Market cap
95.08 bn CNY
P/E (2025)
18.45
P/S (2025)
2.31
Dividend yield
4.92 %
Net margin
12.51 %
Return on equity (ROE)
12.87 %
Return on assets (ROA)
9.50 %

Yunnan Baiyao Group Co Ltd financials

Fiscal year20242025
Revenue40.03 bn CNY41.19 bn CNY
Gross profit11.12 bn CNY12.15 bn CNY
Operating income5.71 bn CNY5.03 bn CNY
EBIT4.59 bn CNY6.07 bn CNY
Net income4.75 bn CNY5.15 bn CNY
Diluted EPS – continuing operations2.66 CNY2.89 CNY

Full history since 1991, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Yunnan Baiyao Group Co Ltd

Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmaceutical supply chain service solutions. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 16.10.2026. Details in the risk notice.

Yunnan Baiyao Group Co Ltd stock (000538.SZ): P/E, revenue, dividend | finmetric